Short Interest in CV Sciences, Inc. (OTCMKTS:CVSI) Declines By 82.5%

CV Sciences, Inc. (OTCMKTS:CVSI) saw a significant decrease in short interest in the month of December. As of December 31st, there was short interest totalling 6,400 shares, a decrease of 82.5% from the December 15th total of 36,600 shares. Based on an average daily trading volume, of 697,100 shares, the days-to-cover ratio is presently 0.0 days.

CV Sciences Stock Down 12.8 %

OTCMKTS CVSI traded down $0.00 on Tuesday, hitting $0.03. The company’s stock had a trading volume of 768,223 shares, compared to its average volume of 398,140. The company’s 50-day moving average is $0.04 and its 200 day moving average is $0.05. The firm has a market cap of $5.54 million, a PE ratio of -3.00 and a beta of 0.66. CV Sciences has a 1-year low of $0.03 and a 1-year high of $0.10.

About CV Sciences

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.